IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v135y2015icp109-116.html
   My bibliography  Save this article

Rationalising prescribing: Evidence, marketing and practice-relevant knowledge

Author

Listed:
  • Wadmann, Sarah
  • Bang, Lia E.

Abstract

Initiatives in the name of ‘rational pharmacotherapy’ have been launched to alter what is seen as ‘inappropriate’ prescribing practices of physicians. Based on observations and interviews with 20 general practitioners (GPs) in 2009–2011, we explored how attempts to rationalise prescribing interact with chronic care management in Denmark. We demonstrate how attempts to rationalise prescribing by informing GPs about drug effects, adverse effects and price do not satisfy GPs' knowledge needs. We argue that, for GPs, ‘rational’ prescribing cannot be understood in separation from the processes that enable patients to use medication. Therefore, GPs do much more to obtain knowledge about medications than seek advice on ‘rational pharmacotherapy’. For instance, GPs also seek opportunities to acquaint themselves with the material objects of medication and medical devices. We conceptualise the knowledge needs of GPs as a need for practice-relevant knowledge and argue that industry sales representatives are granted opportunity to access general practice because they understand this need of GPs.

Suggested Citation

  • Wadmann, Sarah & Bang, Lia E., 2015. "Rationalising prescribing: Evidence, marketing and practice-relevant knowledge," Social Science & Medicine, Elsevier, vol. 135(C), pages 109-116.
  • Handle: RePEc:eee:socmed:v:135:y:2015:i:c:p:109-116
    DOI: 10.1016/j.socscimed.2015.04.032
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953615002701
    Download Restriction: Full text for ScienceDirect subscribers only

    File URL: https://libkey.io/10.1016/j.socscimed.2015.04.032?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Peay, Marilyn Y. & Peay, Edmund R., 1988. "The role of commercial sources in the adoption of a new drug," Social Science & Medicine, Elsevier, vol. 26(12), pages 1183-1189, January.
    2. Schwartz, Rebecca K. & Soumerai, Stephen B. & Avorn, Jerry, 1989. "Physician motivations for nonscientific drug prescribing," Social Science & Medicine, Elsevier, vol. 28(6), pages 577-582, January.
    3. Lambert, Helen, 2006. "Accounting for EBM: Notions of evidence in medicine," Social Science & Medicine, Elsevier, vol. 62(11), pages 2633-2645, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mamas Theodorou & Antonis Kontemeniotis & Marios Kantaris & Antonis Farmakas, 2022. "Disentangling prescribing behaviour of Cypriot physicians, within a complex framework of interacting," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(4), pages 2410-2420, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Timmermans, Stefan & Almeling, Rene, 2009. "Objectification, standardization, and commodification in health care: A conceptual readjustment," Social Science & Medicine, Elsevier, vol. 69(1), pages 21-27, July.
    2. Scott, Clare & Walker, Jan & White, Peter & Lewith, George, 2011. "Forging convictions: The effects of active participation in a clinical trial," Social Science & Medicine, Elsevier, vol. 72(12), pages 2041-2048, June.
    3. Auer, Christian & Lagahid, Jaime Y. & Tanner, Marcel & Weiss, Mitchell G., 2006. "Diagnosis and management of tuberculosis by private practitioners in Manila, Philippines," Health Policy, Elsevier, vol. 77(2), pages 172-181, July.
    4. Pitaknetinan, Kitti & Tangcharoensathien, Viroj & Supachutikul, Anuwat & Bennett, Sara & Mills, Anne, 1999. "Profit, payment and pharmaceutical practices: perspectives from hospitals in Bangkok," Health Policy, Elsevier, vol. 46(3), pages 179-194, March.
    5. Kris Hoang & Steven E. Salterio & Jim Sylph, 2018. "Barriers to Transferring Auditing Research to Standard Setters," Accounting Perspectives, John Wiley & Sons, vol. 17(3), pages 427-452, September.
    6. Reich, Adam, 2012. "Disciplined doctors: The electronic medical record and physicians' changing relationship to medical knowledge," Social Science & Medicine, Elsevier, vol. 74(7), pages 1021-1028.
    7. Sobo, Elisa J. & Bowman, Candice & Gifford, Allen L., 2008. "Behind the scenes in health care improvement: The complex structures and emergent strategies of Implementation Science," Social Science & Medicine, Elsevier, vol. 67(10), pages 1530-1540, November.
    8. Taipale, Jaakko & Hautamäki, Lotta, 2021. "Clinical practice guidelines in courts’ representation of medical evidence and testimony," Social Science & Medicine, Elsevier, vol. 275(C).
    9. Gutin, Iliya, 2022. "Not ‘putting a name to it’: Managing uncertainty in the diagnosis of childhood obesity," Social Science & Medicine, Elsevier, vol. 294(C).
    10. Valentine, Kylie, 2010. "A consideration of medicalisation: Choice, engagement and other responsibilities of parents of children with autism spectrum disorder," Social Science & Medicine, Elsevier, vol. 71(5), pages 950-957, September.
    11. Broom, Alex & Adams, Jon & Tovey, Philip, 2009. "Evidence-based healthcare in practice: A study of clinician resistance, professional de-skilling, and inter-specialty differentiation in oncology," Social Science & Medicine, Elsevier, vol. 68(1), pages 192-200, January.
    12. Nigam, Amit, 2013. "How institutional change and individual researchers helped advance clinical guidelines in American health care," Social Science & Medicine, Elsevier, vol. 87(C), pages 16-22.
    13. Stremersch, S. & Lemmens, A., 2008. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," ERIM Report Series Research in Management ERS-2008-026-MKT, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
    14. van Eijk, Martine E. C. & Krist, Lambert F. G. & Avorn, Jerry & Porsius, Arijan & de Boer, Anthonius, 2001. "Do the research goal and databases match? A checklist for a systematic approach," Health Policy, Elsevier, vol. 58(3), pages 263-274, December.
    15. Behague, Dominique & Tawiah, Charlotte & Rosato, Mikey & Some, Télésphore & Morrison, Joanna, 2009. "Evidence-based policy-making: The implications of globally-applicable research for context-specific problem-solving in developing countries," Social Science & Medicine, Elsevier, vol. 69(10), pages 1539-1546, November.
    16. Green, Sara & Carusi, Annamaria & Hoeyer, Klaus, 2022. "Plastic diagnostics: The remaking of disease and evidence in personalized medicine," Social Science & Medicine, Elsevier, vol. 304(C).
    17. Cho, Mee-Hyun & Yoo, Ki-Bong & Lee, Hoo-Yeon & Lee, Kwang-Sig & Kwon, Jeoung A & Han, Kyu-Tae & Kim, Jae-Hyun & Park, Eun-Cheol, 2015. "The effect of new drug pricing systems and new reimbursement guidelines on pharmaceutical expenditures and prescribing behavior among hypertensive patients in Korea," Health Policy, Elsevier, vol. 119(5), pages 604-611.
    18. Agata Pacho & Emma M Harding-Esch & Emma G Heming De-Allie & Laura Phillips & Martina Furegato & S Tariq Sadiq & Sebastian S Fuller, 2022. "Facilitators and barriers for clinical implementation of a 30-minute point-of-care test for Neisseria gonorrhoeae and Chlamydia trachomatis into clinical care: A qualitative study within sexual health," PLOS ONE, Public Library of Science, vol. 17(3), pages 1-12, March.
    19. Stefan Stremersch & Aurélie Lemmens, 2009. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," Marketing Science, INFORMS, vol. 28(4), pages 690-708, 07-08.
    20. Luminita Mihaela Ion, 2013. "Qualitative Study On Physicians’ Motivations And Drug Prescribing Behaviour," CES Working Papers, Centre for European Studies, Alexandru Ioan Cuza University, vol. 5(1), pages 29-40.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:135:y:2015:i:c:p:109-116. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.